American Academy of Optometry
American Academy of Optometry
November 09, 2018
1 min watch

New in-office treatment addresses MGD

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

SAN ANTONIO – Leslie O’Dell, OD, discussed here at the American Academy of Optometry meeting an up-and-coming product for patients with meibomian gland dysfunction (MGD), Sight Science’s Tear Care.

With the in-office treatment, the eyelids are comfortably heated, then the meibum is cleared from the glands. O’Dell said the patients she has treated report less awareness of their eyes, increased comfort and less eye fatigue.